A Study to Evaluate the Safety and Reactogenicity of DPX-RSV(A), a Respiratory Syncytial Virus Vaccine
Clinical trial NCT02472548 · COMPLETED
Trial details
- NCT number
- NCT02472548
- Sponsor
- Dalhousie University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-05-01
- Primary completion
- 2017-03-14
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.